Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management

[1]  N. Newman,et al.  Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment , 2022, The Lancet Neurology.

[2]  N. Newman,et al.  Imaging of the optic nerve: technological advances and future prospects , 2022, The Lancet Neurology.

[3]  Xiangtian Zhou,et al.  Abnormal morphology and function in retinal ganglion cells derived from patients-specific iPSCs generated from individuals with Leber’s hereditary optic neuropathy , 2022, Human molecular genetics.

[4]  V. Tiranti,et al.  Pathological mitophagy disrupts mitochondrial homeostasis in Leber’s hereditary optic neuropathy , 2022, Cell reports.

[5]  P. Yu-Wai-Man,et al.  Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells , 2022, Human molecular genetics.

[6]  P. Barboni,et al.  Capturing the pattern of transition from carrier to affected in Leber's hereditary optic neuropathy. , 2022, American journal of ophthalmology.

[7]  P. Yu-Wai-Man,et al.  The Impact of Leber Hereditary Optic Neuropathy on the Quality of Life of Patients and Their Relatives: A Qualitative Study , 2022, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[8]  P. Barboni,et al.  The pattern of retinal ganglion cell loss in Wolfram syndrome is distinct from mitochondrial optic neuropathies. , 2022, American journal of ophthalmology-glaucoma.

[9]  M. Bitner-Glindzicz,et al.  WFS1-Associated Optic Neuropathy: Genotype-Phenotype Correlations and Disease Progression. , 2022, American journal of ophthalmology.

[10]  W. Feuer,et al.  Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of all Patient Groups. , 2022, American journal of ophthalmology.

[11]  W. Lagrèze,et al.  DNAJC30 disease-causing gene variants in a large Central European cohort of patients with suspected Leber’s hereditary optic neuropathy and optic atrophy , 2022, Journal of Medical Genetics.

[12]  D. Mackey,et al.  Establishing risk of vision loss in Leber hereditary optic neuropathy , 2021, American journal of human genetics.

[13]  David J. Calkins,et al.  Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates , 2021, Molecular therapy. Methods & clinical development.

[14]  P. Yu-Wai-Man,et al.  Induced Pluripotent Stem Cells for Inherited Optic Neuropathies—Disease Modeling and Therapeutic Development , 2021, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[15]  J. Sahel,et al.  Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy , 2021, International ophthalmology clinics.

[16]  Y. Oh,et al.  Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations. , 2021, Biomaterials.

[17]  P. Yu-Wai-Man,et al.  CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs , 2021, Molecular therapy. Nucleic acids.

[18]  Molly Scannell Bryan,et al.  Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies , 2021, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[19]  Low vision rehabilitation in improving the quality of life for patients with impaired vision: A systematic review and meta-analysis of 52 randomized clinical trials: Retraction , 2021, Medicine.

[20]  Robert W. Taylor,et al.  Mitochondrial disease in adults: recent advances and future promise , 2021, The Lancet Neurology.

[21]  C. Moraes,et al.  Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo , 2021, Nature Communications.

[22]  J. Sahel,et al.  Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison , 2021, Frontiers in Neurology.

[23]  J. Sahel,et al.  Early and late stage gene therapy interventions for inherited retinal degenerations , 2021, Progress in Retinal and Eye Research.

[24]  J. Sahel,et al.  Natural history of patients with Leber hereditary optic neuropathy—results from the REALITY study , 2021, Eye.

[25]  C. Orssaud,et al.  MCAT Mutations Cause Nuclear LHON-like Optic Neuropathy , 2021, Genes.

[26]  V. Carelli,et al.  Molecular Mechanisms behind Inherited Neurodegeneration of the Optic Nerve , 2021, Biomolecules.

[27]  J. Sahel,et al.  Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study , 2021, BioDrugs.

[28]  T. Strom,et al.  Impaired complex I repair causes recessive Leber’s hereditary optic neuropathy , 2021, The Journal of clinical investigation.

[29]  J. Sahel,et al.  Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset. , 2021, Ophthalmology.

[30]  C. Mitsch,et al.  Changes in Visual Function and Correlations with Inner Retinal Structure in Acute and Chronic Leber’s Hereditary Optic Neuropathy Patients after Treatment with Idebenone , 2021, Journal of clinical medicine.

[31]  P. Yu-Wai-Man,et al.  Dominant optic atrophy: Culprit mitochondria in the optic nerve , 2020, Progress in Retinal and Eye Research.

[32]  David J. Calkins,et al.  Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy , 2020, Science Translational Medicine.

[33]  P. Barboni,et al.  Therapeutic Options in Hereditary Optic Neuropathies , 2020, Drugs.

[34]  N. Newman,et al.  Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy , 2020, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[35]  N. Newman,et al.  Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation. , 2020, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[36]  John J. Chen,et al.  Nuclear DNA mutation causing a phenotypic Leber hereditary optic neuropathy plus. , 2020, Ophthalmology.

[37]  J. Sahel,et al.  Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study , 2020, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[38]  Nektarios Tavernarakis,et al.  Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy , 2020, Nature Communications.

[39]  David R. Liu,et al.  A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing , 2020, Nature.

[40]  P. Chinnery.  Mitochondrial Replacement in the Clinic. , 2020, New England Journal of Medicine.

[41]  Makoto Nakamura,et al.  A Single-Arm, Prospective, Exploratory Study to Preliminarily Test Effectiveness and Safety of Skin Electrical Stimulation for Leber Hereditary Optic Neuropathy , 2020, Journal of clinical medicine.

[42]  F. Urano,et al.  Gene-edited human stem cell–derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice , 2020, Science Translational Medicine.

[43]  P. Barboni,et al.  Idebenone increases chance of stabilization/recovery of visual acuity in OPA1‐dominant optic atrophy , 2020, Annals of clinical and translational neurology.

[44]  G. Savini,et al.  Calcium mishandling in absence of primary mitochondrial dysfunction drives cellular pathology in Wolfram Syndrome , 2020, Scientific Reports.

[45]  M. Kalloniatis,et al.  A holistic model of low vision care for improving vision‐related quality of life , 2020, Clinical & experimental optometry.

[46]  Jian Sun,et al.  Seven-Year Follow-up of Gene Therapy for Leber's Hereditary Optic Neuropathy. , 2020, Ophthalmology.

[47]  Xin Li,et al.  Factors associated with rapid improvement in visual acuity in patients with Leber's hereditary optic neuropathy after gene therapy. , 2020, Acta ophthalmologica.

[48]  B. Heindryckx,et al.  Comparative analysis of different nuclear transfer techniques to prevent the transmission of mitochondrial DNA variants. , 2019, Molecular human reproduction.

[49]  B. Pemp,et al.  Visual function in chronic Leber’s hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[50]  J. Sahel,et al.  Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial , 2019, JAMA ophthalmology.

[51]  B. Delprat,et al.  ER-mitochondria cross-talk is regulated by the Ca2+ sensor NCS1 and is impaired in Wolfram syndrome , 2018, Science Signaling.

[52]  R. Bowman,et al.  Clinical utility gene card for: inherited optic neuropathies including next-generation sequencing-based approaches , 2018, European Journal of Human Genetics.

[53]  B. Ravina,et al.  Gene therapy for neurological disorders: progress and prospects , 2018, Nature Reviews Drug Discovery.

[54]  G. Lenaers,et al.  OPA1: How much do we know to approach therapy? , 2018, Pharmacological research.

[55]  C. Tilikete,et al.  Cyclosporine A does not prevent second-eye involvement in Leber’s hereditary optic neuropathy , 2018, Orphanet Journal of Rare Diseases.

[56]  G. Lenaers,et al.  OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model , 2018, Scientific Reports.

[57]  N. Newman,et al.  International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy , 2017, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[58]  W. Hauswirth,et al.  Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results. , 2017, Ophthalmology.

[59]  C. La Morgia,et al.  Incomplete penetrance in mitochondrial optic neuropathies. , 2017, Mitochondrion.

[60]  N. Newman,et al.  Inherited eye-related disorders due to mitochondrial dysfunction , 2017, Human molecular genetics.

[61]  C. La Morgia,et al.  Optic neuropathies: the tip of the neurodegeneration iceberg , 2017, Human molecular genetics.

[62]  Bireswar Laha,et al.  Regenerating optic pathways from the eye to the brain , 2017, Science.

[63]  M. Votruba,et al.  Childhood-onset Leber hereditary optic neuropathy , 2017, British Journal of Ophthalmology.

[64]  Matthew J. Daniels,et al.  Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations , 2017, Neurology.

[65]  A. Munnich,et al.  Compound heterozygosity for severe and hypomorphic NDUFS2 mutations cause non-syndromic LHON-like optic neuropathy , 2016, Journal of Medical Genetics.

[66]  Valérie Biousse,et al.  Diagnosis and clinical features of common optic neuropathies , 2016, The Lancet Neurology.

[67]  S. Benes,et al.  Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy , 2016, Neural regeneration research.

[68]  P. Barboni,et al.  A neurodegenerative perspective on mitochondrial optic neuropathies , 2016, Acta Neuropathologica.

[69]  G. Lenaers,et al.  WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity. , 2016, Ophthalmology.

[70]  C. Chen,et al.  Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy , 2016, EBioMedicine.

[71]  W. Feuer,et al.  Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results. , 2016, Ophthalmology.

[72]  C. Chen,et al.  Efficacy and Safety of rAAV2-ND4 Treatment for Leber’s Hereditary Optic Neuropathy , 2016, Scientific Reports.

[73]  Robert W. Taylor,et al.  Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation , 2015, Journal of Medical Genetics.

[74]  R. Schüle,et al.  Mutations in the UGO1-like protein SLC25A46 cause an optic atrophy spectrum disorder , 2015, Nature Genetics.

[75]  Robert W. Taylor,et al.  Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.

[76]  V. Desquiret-Dumas,et al.  Early-onset Behr syndrome due to compound heterozygous mutations in OPA1. , 2014, Brain : a journal of neurology.

[77]  P. Chinnery,et al.  Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates. , 2013, Ophthalmology.

[78]  P. Chinnery,et al.  Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy , 2012, Brain : a journal of neurology.

[79]  P. Barboni,et al.  Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. , 2012, Archives of neurology.

[80]  P. Chinnery,et al.  A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy , 2011, Brain : a journal of neurology.

[81]  Giovanni Rizzo,et al.  Idebenone treatment in Leber's hereditary optic neuropathy. , 2011, Brain : a journal of neurology.

[82]  P. Chinnery,et al.  Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies , 2011, Progress in Retinal and Eye Research.

[83]  Robert W. Taylor,et al.  The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. , 2010, Ophthalmology.

[84]  P. Plevani,et al.  Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28 , 2010, Nature Genetics.

[85]  D. Turnbull,et al.  Multi-system neurological disease is common in patients with OPA1 mutations , 2010, Brain : a journal of neurology.

[86]  P. Chinnery,et al.  Quality of life in patients with leber hereditary optic neuropathy. , 2009, Investigative ophthalmology & visual science.

[87]  F. Baas,et al.  Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2 , 2006, Annals of neurology.

[88]  J. Trobe.  Walsh & Hoyt??s Clinical Neuro-Ophthalmology, 6th Edition , 2005 .

[89]  M. T. Bhatti,et al.  Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. , 2005, American journal of ophthalmology.

[90]  V. Carelli,et al.  Mitochondrial dysfunction as a cause of optic neuropathies , 2004, Progress in Retinal and Eye Research.

[91]  D. Turnbull,et al.  The epidemiology of Leber hereditary optic neuropathy in the North East of England. , 2003, American journal of human genetics.

[92]  E. Schon,et al.  Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy , 2002, Annals of neurology.

[93]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[94]  D. Vetrie,et al.  A novel X–linked gene, DDP, shows mutations in families with deafness (DFN–1), dystonia, mental deficiency and blindness , 1996, Nature Genetics.

[95]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[96]  M. Sanders,et al.  The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. , 1995, Brain : a journal of neurology.

[97]  OUP accepted manuscript , 2022, Brain.

[98]  Albert and Jakobiec's Principles and Practice of Ophthalmology , 2020 .

[99]  P. Chinnery,et al.  Disturbed mitochondrial dynamics and neurodegenerative disorders , 2015, Nature Reviews Neurology.

[100]  D. Manners,et al.  Visual system involvement in patients with Friedreich's ataxia. , 2009, Brain : a journal of neurology.